Company Filing History:
Years Active: 2014-2024
Title: The Innovative Contributions of Susan Jane Tzotzos
Introduction
Susan Jane Tzotzos is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for lung treatment. With a total of 2 patents, her work is paving the way for advancements in medical therapies.
Latest Patents
Tzotzos's latest patents include a pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2, which is used for extracorporeal lung treatment. This method focuses on conditioning and improving lung functions extracorporeally by treating a non-ischemic donor lung ex vivo with a cyclized compound of the specified amino acid sequence. Additionally, she has developed an organic compound for the regulation of vectorial ion channels. This cyclic organic compound consists of 16 or 17 amino acids and is designed to treat diseases associated with lung function and oedemas.
Career Highlights
Susan Jane Tzotzos is currently associated with Apeptico Forschung und Entwicklung GmbH, where she continues to innovate in the pharmaceutical sector. Her expertise in cyclic peptides and organic compounds has positioned her as a key player in her field.
Collaborations
Throughout her career, Tzotzos has collaborated with notable colleagues, including Bernhard Fischer and Hendrik Fischer. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Susan Jane Tzotzos exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions are not only advancing medical science but also improving patient outcomes in lung health.